Subscribe
Kawasaki disease
Does Kawasaki disease rash itch?
Kawasaki disease, once called mucocutaneous lymph node syndrome, is a disease of unknown cause and unclear pathogenesis. It is characterized by systemic vasculitis. Clinically, it mainly presents with fever, conjunctival congestion, cracked lips, congested oral mucosa, diffuse congestion, strawberry tongue, acute stage swelling and erythema of the hands and feet, polymorphous rash, and scarlet fever-like skin rash. It is often associated with unilateral or bilateral lymphadenopathy, which is not red on the surface, but the lymph nodes are hard and tender to the touch. It frequently involves complications such as myocarditis or pericarditis, with common coronary artery damage. The rash seen in Kawasaki disease is a manifestation of vasculitis and is generally non-itchy.
What should be paid attention to in the diet for Kawasaki disease?
Kawasaki disease is a type of mucocutaneous lymph node syndrome, and its main pathological change is systemic vasculitis. Its main characteristics include persistent fever, high fever, ineffective antibiotic treatment, followed by the appearance of a skin rash on the mucous membranes, accompanied by enlarged lymph nodes. When Kawasaki disease occurs, there is a high fever, so it is suggested that children with Kawasaki disease should consume a diet high in protein, calories, and fiber, which is light and easily digestible in liquid or semi-liquid form. Spicy, overly hard, and overly hot foods should be avoided.
How many days can Kawasaki disease be cured?
Kawasaki disease is a syndrome of mucocutaneous lymph node syndrome, the cause of which is unclear, as is the pathogenesis of the disease. The pathological changes are mainly systemic vasculitis, which is prone to secondary damage to the coronary arteries. It has a relatively long course. If fever occurs, the fever can persist for 1-2 weeks. Generally, special medications such as aspirin are required for treatment. Usually, treatment is for 3 days, and after the fever subsides, the dosage is gradually reduced, maintained for 6-8 weeks. If there is secondary coronary artery damage, the duration might be longer. In cases of severe coronary damage, the duration of the disease may be several months or even years, depending on the specific condition of the disease. Kawasaki disease is a self-limiting disease. Usually, if there is no significant coronary artery damage, after symptom control, comprehensive examinations are conducted 1 month, 3 months, 6 months, and 1-2 years after discharge, mainly heart examinations such as electrocardiograms and echocardiograms. If there is a combination of coronary artery aneurysms, long-term follow-up is required, with an examination every six months to one year until the coronary aneurysm disappears or if there is combined damage to the coronary artery structure, long-term follow-up is needed.
How long does it take to cure Kawasaki disease?
Kawasaki disease, also known as mucocutaneous lymph node syndrome, has unclear etiology and pathogenesis. The primary pathological change is systemic vasculitis, frequently affecting the coronary arteries. Kawasaki disease is considered a self-limiting condition, with most cases having a good prognosis; recurrence occurs in 1% to 2% of affected children. If associated with coronary artery damage and not effectively treated, 15% to 25% of these cases can develop coronary artery aneurysms. Typically, coronary artery aneurysms resolve within two years of onset, but often leave residual arterial wall thickening and reduced elasticity. Large aneurysms do not disappear completely and can lead to thrombosis or stenosis. Kawasaki disease is also one of the main causes of acquired heart disease in children. Therefore, active and effective treatment of Kawasaki disease can result in recovery. However, if there is accompanying coronary artery damage, the prognosis can vary depending on the extent of the damage. Severe coronary artery damage might lead to long-term heart disease.
How long to take aspirin for Kawasaki disease
The current pathogenesis of Kawasaki disease is not yet clear, but one of its main pathological changes is a systemic vasculitis. During an outbreak of Kawasaki disease, the blood viscosity increases primarily due to platelet aggregation. Typically, oral aspirin is administered to prevent this inflammation and to treat platelet aggregation. The dosage is generally reduced gradually once the fever subsides, with maintenance doses lasting about six to eight weeks. If coronary artery lesions are present, the duration of medication is extended until the coronary arteries return to normal before discontinuing the drug.
What should not be eaten with Kawasaki disease?
One of the main pathological changes in Kawasaki disease is systemic vasculitis. Clinically, common symptoms include fever, high fever, recurrent fever, conjunctival congestion, significant oral mucosal congestion, strawberry tongue, enlargement of neck lymph nodes, and peeling of the hands and feet. In cases of Kawasaki disease, oral mucosal congestion is a common complication, hence during the period of Kawasaki disease, it is advised not to consume irritating, spicy, or hot foods. These might exacerbate the child's discomfort, affect their nutrient absorption, and potentially worsen the condition. Therefore, during the illness, it is preferable to focus on bland, easy-to-digest foods.
Is Kawasaki disease contagious?
Kawasaki disease, also known as mucocutaneous lymph node syndrome, currently has unclear pathogenic mechanisms and the causes of the disease are not well defined. One of its main pathological changes is systemic vasculitis, including the coronary arteries. The disease occurs sporadically or in small epidemics, can happen in any season without clear seasonality, and is generally more common in infants and young children, with eighty percent under five years of age. Kawasaki disease is not a contagious disease, so it does not have significant contagiousness.
Does Kawasaki disease cause coughing?
Kawasaki disease has an unclear pathogenesis, primarily manifesting as systemic vasculitis, frequently affecting the coronary arteries. Clinically, it is characterized by fever, typically a high fever lasting seven to fourteen days, and is unresponsive to antibiotic treatment. Other symptoms include conjunctival congestion, cracked lips, diffuse oral congestion, and strawberry tongue. In the acute phase, there might be hard edema and erythema development, with polymorphous erythema and scarlatiniform rash typically on the trunk. Additionally, unilateral or bilateral cervical lymphadenopathy with tenderness can occur. Generally, coughing is rare and may be due to other infections like upper respiratory infections in children with weaker immunity.
What is Kawasaki disease?
Kawasaki disease is a disease possibly related to viruses. Currently, the exact cause of Kawasaki disease is unclear, and the mechanism of its onset is also not well understood. It is characterized primarily by systemic vasculitis and is an acute febrile exanthematous disease. Clinically, it presents with symptoms such as rash, fever, conjunctival congestion, cracked lips, oral mucosal congestion, enlarged cervical lymph nodes, and peeling of the skin on the extremities. The cause of Kawasaki disease is unclear, but various viral infections observed clinically could potentially exacerbate the progression of Kawasaki disease. It mainly affects the coronary arteries, so there is a certain link between Kawasaki disease and viruses. However, it is not necessarily the direct cause of Kawasaki disease but could worsen or be a concomitant disease.
Is Kawasaki disease easy to treat?
Kawasaki disease, also known as mucocutaneous lymph node syndrome, is a self-limiting disease but is an acute systemic vasculitis commonly seen in infants and children under the age of 5. The primary clinical manifestations include non-suppurative cervical lymphadenopathy, oral mucosal lesions, conjunctival congestion, prolonged fever, polymorphous rash, and hard swelling of the hands and feet with fingertip desquamation. Cardiovascular damage is the most severe complication of Kawasaki disease and can lead to coronary artery aneurysms and coronary artery dilation. If Kawasaki disease is not treated promptly, the incidence of developing coronary artery aneurysms is 15%-25%, making Kawasaki disease one of the most common causes of acquired heart disease in infants and young children. Therefore, timely treatment of Kawasaki disease is crucial, generally involving anti-inflammatory treatment, immune support, and symptomatic management. If there is no concomitant coronary artery damage, treatment involves symptomatic management. If there is coronary artery damage, the treatment duration will be longer and regular follow-up is necessary. The course of the disease can extend over months or even years, thus treatment of Kawasaki disease needs to be tailored based on the individual's condition and clinical symptoms.